Kowalski, Jonathan W.
1124  Ergebnisse:
Personensuche X
?
3

Clinical Utilization of Anti-VEGF Agents and Disease Monito..:

Holekamp, Nancy M. ; Liu, Ying ; Yeh, Wei-Shi...
American Journal of Ophthalmology.  157 (2014)  4 - p. 825-833.e1 , 2014
 
?
11

Botulinum toxin type A in the treatment of primary axillary..:

Lowe, Nicholas J. ; Glaser, Dee Anna ; Eadie, Nina...
Journal of the American Academy of Dermatology.  56 (2007)  4 - p. 604-611 , 2007
 
?
12

Validity and reliability of the hyperhidrosis disease sever..:

Kowalski, Jonathan W. ; Eadie, Nina ; Dagget, Simon.
Journal of the American Academy of Dermatology.  50 (2004)  3 - p. P51 , 2004
 
?
13

US prevalence of hyperhidrosis and impact on individuals wi..:

Strutton, David R ; Kowalski, Jonathan W ; PharmD..
Journal of the American Academy of Dermatology.  51 (2004)  2 - p. 241-248 , 2004
 
?
14

Quality-of-life effect of botulinum toxin type a on patient..:

Kowalski, Jonathan W. ; Glaser, Dee Anna ; Lowe, Nicholas J..
Journal of the American Academy of Dermatology.  50 (2004)  3 - p. P50 , 2004
 
?
15

Effects of oral tazarotene on health-related quality of lif..:

Kowalski, Jonathan W ; Leyden, James J ; Tan, Jerry.
Journal of the American Academy of Dermatology.  50 (2004)  3 - p. P18 , 2004
 
1-15